The technology is available on the new MyLab™E85 GTS Edition that will be showcased together with the brand new MyLab™C30 GTS ...
Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) procedures in Arizona using the Vanquish® Water ...
URO-1, Inc. is a life sciences company dedicated to advancing the tools and workflows used in soft tissue biopsy diagnostics.
DPA International on MSN
What actually happens in a prostate cancer screening?
While many people are familiar with mammograms and smear tests, prostate screening is talked about far less. To shed light on this important subject ahead of Prostate Cancer Awareness Month in March, ...
Medical Device Network on MSN
Francis Medical concludes first commercial procedures with Vanquish system
Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.
Overview of Ac‑225 PSMA therapy, what real patient cases can illustrate about the treatment pathway, and key steps for eligibility review and choosing a center.
Urologists, radiologists and pathologists from Europe and the US agreed an “expert consensus statement” on prostate cancer treatment and diagnosis ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...
First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results